Report #2873008

Received Nov 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (2)

PainPyrexia

Symptom narrative

sight fever; soreness and sight fever after the shot; This non-serious case was reported by a consumer via call center representative and described the occurrence of fever in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fever (Verbatim: sight fever) and pain (Verbatim: soreness and sight fever after the shot). The outcome of the fever and pain were not reported. It was unknown if the reporter considered the fever and pain to be related to Shingrix. It was unknown if the company considered the fever and pain to be related to Shingrix. Additional Information: GSK Receipt Date: 11-NOV-2025 The patient asked can take Advil for the soreness and sight fever after the shot.